DK457779A - Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater - Google Patents

Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater

Info

Publication number
DK457779A
DK457779A DK457779A DK457779A DK457779A DK 457779 A DK457779 A DK 457779A DK 457779 A DK457779 A DK 457779A DK 457779 A DK457779 A DK 457779A DK 457779 A DK457779 A DK 457779A
Authority
DK
Denmark
Prior art keywords
hydroxy
preparing
procedure
pyrone derivatives
pyrone
Prior art date
Application number
DK457779A
Other languages
Danish (da)
English (en)
Inventor
H Oka
A Terahara
A Endro
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of DK457779A publication Critical patent/DK457779A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30Oxygen atoms, e.g. delta-lactones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
DK457779A 1978-10-30 1979-10-30 Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater DK457779A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP13340678A JPS5559180A (en) 1978-10-30 1978-10-30 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Publications (1)

Publication Number Publication Date
DK457779A true DK457779A (da) 1980-05-01

Family

ID=15104002

Family Applications (1)

Application Number Title Priority Date Filing Date
DK457779A DK457779A (da) 1978-10-30 1979-10-30 Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater

Country Status (4)

Country Link
US (1) US4255444A (fr)
EP (1) EP0010951A1 (fr)
JP (1) JPS5559180A (fr)
DK (1) DK457779A (fr)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU535944B2 (en) * 1979-06-15 1984-04-12 Merck & Co., Inc. Hypocholestermic fermentation products from aspergillus
US4710513A (en) * 1979-08-17 1987-12-01 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4567289A (en) * 1979-08-17 1986-01-28 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
US4459422A (en) * 1979-08-17 1984-07-10 Merck & Co., Inc. Substituted pyranone inhibitors of cholesterol synthesis
IL60751A (en) * 1979-08-17 1985-04-30 Merck & Co Inc 6-(2'-((substituted phenyl)ethyl and-ethenyl)-4-hydroxy-tetrahydro-2h-pyran-2-one derivatives,their preparation and pharmaceutical compositions containing them
US4293496A (en) * 1980-02-04 1981-10-06 Merck & Co., Inc. 6(R)-[2-(8-Hydroxy-2,6-dimethylpolyhydronaphthyl-1)-ethyl]-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
EP0068038B1 (fr) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4R.6S)-(E)-6-(2-(4'-fluoro-3,3',5-triméthyl-(1,1'-biphényl)-2-yle)éthenyl)-3,4,5,6-tétrahydro-4-hydroxy-2H-pyran-2-one, un procédé pour sa fabrication et une composition pharmaceutique la contenant
US4739073A (en) * 1983-11-04 1988-04-19 Sandoz Pharmaceuticals Corp. Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
US5354772A (en) * 1982-11-22 1994-10-11 Sandoz Pharm. Corp. Indole analogs of mevalonolactone and derivatives thereof
CA1282425C (fr) * 1984-06-04 1991-04-02 Meyer Sletzinger Procede de preparation d'inhibiteurs de la hmg-coa reductase avec une sous-unite de 3,5-dihihydroxypentanoate
US4645854A (en) * 1985-04-25 1987-02-24 Merck & Co., Inc. Process for preparing HMG-CoA reductase inhibitors with a 3,5-dihydroxypentanoate subunit
US4588715A (en) * 1984-06-04 1986-05-13 Sandoz, Inc. Heptenoic acid derivatives
US4613610A (en) * 1984-06-22 1986-09-23 Sandoz Pharmaceuticals Corp. Cholesterol biosynthesis inhibiting pyrazole analogs of mevalonolactone and its derivatives
US4686237A (en) * 1984-07-24 1987-08-11 Sandoz Pharmaceuticals Corp. Erythro-(E)-7-[3'-C1-3 alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl]-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4804679A (en) * 1984-07-24 1989-02-14 Sandoz Pharm. Corp. Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl)-3,5-dihydroxyhept-6-enoic acids and derivatives thereof
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
US5001255A (en) * 1984-12-04 1991-03-19 Sandoz Pharm. Corp. Idene analogs of mevalonolactone and derivatives thereof
US4622338A (en) 1985-03-11 1986-11-11 G. D. Searle & Co. Substituted glutaric acid lactones in the treatment of hyperlipidemia
US4668794A (en) * 1985-05-22 1987-05-26 Sandoz Pharm. Corp. Intermediate imidazole acrolein analogs
EP0204287A3 (fr) * 1985-06-04 1987-07-01 Merck & Co. Inc. Procédé de préparation d'inhibiteurs de la HMG-CoA réductase ayant des sous-groupes 3,5-dihydroxy pentanoiques
DE3674521D1 (de) 1985-08-29 1990-10-31 Hoechst Ag 6-phenoxymethyl-4-hydroxytetrahydropyran-2-one, verfahren zu ihrer herstellung, ihre verwendung als arzneimittel, pharmazeutische praeparate und zwischenprodukte.
US4851427A (en) * 1985-10-25 1989-07-25 Sandoz Pharm. Corp. Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use
US4654363A (en) * 1985-11-04 1987-03-31 Merck & Co., Inc. Synthetic analogs of mevinolin
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4681893A (en) * 1986-05-30 1987-07-21 Warner-Lambert Company Trans-6-[2-(3- or 4-carboxamido-substituted pyrrol-1-yl)alkyl]-4-hydroxypyran-2-one inhibitors of cholesterol synthesis
US4957971A (en) * 1986-07-07 1990-09-18 Warner-Lambert Company Trans-6-(2-(N-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl)-or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US5102893A (en) * 1986-07-07 1992-04-07 Warner-Lambert Company Trans-6-(2-(n-heteroaryl-3,5-disubstituted)pyrazol-4-yl)-ethyl- or ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
NZ221717A (en) * 1986-09-10 1990-08-28 Sandoz Ltd Azaindole and indolizine derivatives and pharmaceutical compositions
US4751235A (en) * 1986-12-23 1988-06-14 Sandoz Pharm. Corp. Anti-atherosclerotic indolizine derivatives
AT388162B (de) * 1987-10-08 1989-05-10 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-beta-phenylaethyl- und 6(s)-beta-styryltetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung und pharmazeutische praeparate auf basis dieser verbindungen
WO1989003212A1 (fr) * 1987-10-13 1989-04-20 Pfizer Inc. Acides 3,5-dihydroxy-6,8-non adienoiques et leurs derives en tant qu'agents hypocholesterolemiques
US4761419A (en) * 1987-12-07 1988-08-02 Warner-Lambert Company 6-(((substituted)quinolinyl)ethyl)-and ethenyl)tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
US4863957A (en) * 1987-12-21 1989-09-05 Rorer Pharmaceutical Corporation Novel HMG-CoA reductase inhibitors
US4822799A (en) * 1988-01-27 1989-04-18 Sandoz Pharm. Corp. Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals
US4906657A (en) * 1988-12-21 1990-03-06 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US4957940A (en) * 1988-12-21 1990-09-18 Warner-Lambert Company Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
US4997849A (en) * 1989-06-23 1991-03-05 Merck & Co., Inc. Microbial transformation of simvastatin
US5025017A (en) * 1989-09-28 1991-06-18 E. R. Squibb & Sons, Inc. Seco-mevinic acid derivatives useful as antihypercholesterolemic agents and new intermediates
WO1992019239A1 (fr) * 1991-05-01 1992-11-12 University Of New Mexico Traitement d'etats cellulaires aberrants a l'aide de biomodulateurs
WO1992019240A1 (fr) * 1991-05-01 1992-11-12 University Of New Mexico Traitement d'aberrations cellulaires avec des biomodulateurs
CA2118796A1 (fr) * 1991-09-20 1993-04-01 John Crosby Pyranones
CA2118795A1 (fr) * 1991-09-20 1993-04-01 John Crosby Pyranones
US5296220A (en) * 1992-12-07 1994-03-22 Roelofs Wendell L Cockroach attractant
US7304091B2 (en) * 2001-12-03 2007-12-04 Myco Teo A/S Statin-like compounds
US20050182125A1 (en) * 2003-05-16 2005-08-18 Ambit Biosciences Corporation Pyrrole compounds and uses thereof
US20040248972A1 (en) * 2003-05-16 2004-12-09 Ambit Biosciences Corporation Compounds and uses thereof
EP1626713A2 (fr) * 2003-05-16 2006-02-22 Ambit Biosciences Corporation Composes heterocycliques et leurs utilisations
US7250444B2 (en) * 2003-08-11 2007-07-31 Pfizer Inc. Pyrrole-based HMG-CoA reductase inhibitors
EP1691803A1 (fr) * 2003-12-05 2006-08-23 Warner-Lambert Company LLC Pyrroles de n-alkyl comme inhibiteurs de l'hmg-coa-reductase
WO2006123355A2 (fr) * 2004-11-03 2006-11-23 Sun Pharmaceutical Industries Limited Nouveaux derives de statine
US20090183503A1 (en) * 2008-01-18 2009-07-23 Alberto Verdesi Exhaust apparatus
EP3277274B1 (fr) 2015-04-01 2024-06-12 Cedars-Sinai Medical Center Analogues ou dérivés de lovastatine anti-méthanogènes et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4049495A (en) * 1974-06-07 1977-09-20 Sankyo Company Limited Physiologically active substances and fermentative process for producing the same
JPS5612114B2 (fr) * 1974-06-07 1981-03-18
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives

Also Published As

Publication number Publication date
US4255444A (en) 1981-03-10
EP0010951A1 (fr) 1980-05-14
JPS5559180A (en) 1980-05-02

Similar Documents

Publication Publication Date Title
DK363179A (da) Fremgangsmaade til fremstilling af tetrazolylalkoxycarbostyrilderivater
DK457779A (da) Fremgangsmaade til fremstilling af 4-hydroxy-2-pyronderivater
DK128679A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK488379A (da) Fremgangsmaade til fremstilling af polyetherderivater
DK425579A (da) Fremgangsmaade til fremstilling af heterocycliske forbindelser
DK7579A (da) Fremgangsmaade til fremstilling af (%n-diethylmeta-toluamid
DK19579A (da) Fremgangsmaade til fremstilling af spirothienohydantoinderivater
DK50779A (da) Fremgangsmaade til fremstilling af piperazinderivater
DK539578A (da) Fremgangsmaade til fremstilling af pleuromutilinglycsid-derivater
DK531178A (da) Fremgangsmaade til fremstilling af phenylglycinderivater
DK145698C (da) Analogifremgangsmaade til fremstilling af 2-alkoxyadeninderivater
DK186179A (da) Fremgangsmaade til fremstilling af carbapenemderivater
DK138879A (da) Fremgangsmaade til fremstilling af lysergolderivater
DK147145C (da) Analogifremgangsmaade til fremstilling af chlorambucilderivater
DK161198C (da) Analogifremgangsmaade til fremstilling af substituerede omega-aroylpropionyl-l-proliner
DK152130C (da) Fremgangsmaade til fremstilling af benzooebaathienopyridinderivater
DK494978A (da) Fremgangsmaade til fremstilling af 2-iminoimidazolidinderivater
DK330279A (da) Fremgangsmaade til fremstilling af soem
DK130079A (da) Fremgangsmaade til fremstilling af pyridopyrimidin-derivater
DK160281C (da) Fremgangsmaade til fremstilling af steroid-s-thioesterderivater
DK520178A (da) Fremgangsmaade til fremstilling af phenoxyalkanolamin-derivater
DK12879A (da) R fremgangsmaade til fremstilling af ergopeptidalkaloidderivate
DK157979A (da) Fremgangsmaade til fremstilling af benzomorphanderivater
DK250679A (da) Fremgangsmaade til fremstilling af 2-isopropylaminopyrimidin
DK260079A (da) Fremgangsmaade til fremstilling af phenoxyalkylamid-derivater